Skip to main content
Genmab A/S (CPH: GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,873.50
-4.00 (-0.21%)
Aug 30, 2024, 4:59 PM CET

Genmab Market Cap

Genmab has a market cap or net worth of 118.96 billion as of August 30, 2024. Its market cap has decreased by -26.64% in one year.

Market Cap
118.96B
Enterprise Value
104.24B
Revenue
19.02B
Ranking
n/a
PE Ratio
22.19
Stock Price
1,873.50

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 118.96B, an increase of 3,128.82%. That is a compound annual growth rate of 15.66%.

History

DateMarket Cap% Change
Aug 30, 2024118.96B-15.50%
Dec 29, 2023140.77B-26.77%
Dec 30, 2022192.23B11.72%
Dec 30, 2021172.06B6.80%
Dec 30, 2020161.11B67.11%
Dec 30, 201996.41B46.85%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Novo Nordisk A/S 4,000.40B
Coloplast A/S 203.39B
Demant A/S 61.26B
Zealand Pharma A/S 61.04B
H. Lundbeck A/S 46.10B
H. Lundbeck A/S 46.10B
ALK-Abelló A/S 39.37B
Ambu A/S 38.76B
Market Cap Rankings